Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (143659)	1/15/2002 9:18:15 AM
From: JHP	Read Replies (1) \| Respond to of 436258

Mike in todays boston globe GZTC Monkeying with mice and malaria A malaria vaccine made from the milk of genetically modified mice seems to work in monkeys. Anthony Stowers of the US National Institute of Allergy and Infectious Disease, working together with Genzyme, used a strain of mice carrying a gene that codes for a surface protein from the malaria parasite, Plasmodium falciparum. This gene was switched on in cells that line the mouse mammary glands so that the protein winds up in the milk and primes the monkey's immune system against the disease. Clinical trials on people could start as soon as next year. ref.: Proceedings of the National Academy of Science, Dec. 18, 2001. regards john